Artivion Stock Today
| AORT Stock | USD 24.12 0.70 2.99% |
PerformanceVery Weak
| Odds Of DistressLow
|
Artivion is selling for under 24.12 as of the 16th of March 2025; that is 2.99 percent increase since the beginning of the trading day. The stock's last reported lowest price was 23.59. Artivion has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Note, on November 20, 2023, Senator Tina Smith of US Senate acquired $50k to $100k worth of Artivion's common stock.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company was founded in 1984 and is headquartered in Kennesaw, Georgia. Artivion operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 42.05 M outstanding shares of which 3.83 M shares are presently shorted by private and institutional investors with about 8.96 trading days to cover. More on Artivion
Moving against Artivion Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Artivion Stock Highlights
Artivion (AORT) is traded on New York Stock Exchange in USA. It is located in 1655 Roberts Boulevard NW, Kennesaw, GA, United States, 30144 and employs 1,600 people. Artivion is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.01 B. Artivion conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 42.05 M outstanding shares of which 3.83 M shares are presently shorted by private and institutional investors with about 8.96 trading days to cover.
Artivion currently holds about 40.38 M in cash with 22.24 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.0.
Check Artivion Probability Of Bankruptcy
Ownership AllocationArtivion holds a total of 42.05 Million outstanding shares. The majority of Artivion outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Artivion to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Artivion. Please pay attention to any change in the institutional holdings of Artivion as this could imply that something significant has changed or is about to change at the company. On November 20, 2023, Senator Tina Smith of US Senate acquired $50k to $100k worth of Artivion's common stock.
Check Artivion Ownership Details
Artivion Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Artivion market risk premium is the additional return an investor will receive from holding Artivion long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | (1.09) |
Artivion Stock Against Markets
Artivion Corporate Management
| Daniel Bevevino | Independent Director | Profile | |
| Jean Holloway | Senior Vice President Chief Compliance Officer, General Counsel, Secretary | Profile | |
| Jon Salveson | Independent Director | Profile | |
| Andrew Green | Vice President - Regulatory Affairs | Profile | |
| Thomas Ackerman | Independent Director | Profile | |
| Rochelle Maney | Vice President - Global Quality Assurance | Profile |
Already Invested in Artivion?
The danger of trading Artivion is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Artivion is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Artivion. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Artivion is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Artivion Stock Analysis
When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.